Aeclat Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-12-2024
- Paid Up Capital ₹ 0.50 M
as on 30-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 30-12-2024
- Revenue -6.10%
(FY 2022)
- Profit 12.71%
(FY 2022)
- Ebitda 13.20%
(FY 2022)
- Net Worth 7.15%
(FY 2022)
- Total Assets 31.01%
(FY 2022)
About Aeclat Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.00 M.
Anish Buchasia, Ravi Kejriwal, and Alok Sharma serve as directors at the Company.
- CIN/LLPIN
U24100GJ2012PTC068935
- Company No.
068935
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aeclat Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anish Buchasia  | Director | 15-Dec-2021 | Current |
| Ravi Kejriwal | Director | 20-May-2024 | Current |
| Alok Sharma | Director | 01-Jun-2015 | Current |
Financial Performance of Aeclat Lifesciences.
Aeclat Lifesciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.1% decrease. The company also saw a substantial improvement in profitability, with a 12.71% increase in profit. The company's net worth moved up by a moderate rise of 7.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aeclat Lifesciences?
In 2021, Aeclat Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Nov 2020 | ₹3.00 M | Open |
How Many Employees Work at Aeclat Lifesciences?
Aeclat Lifesciences has a workforce of 13 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aeclat Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aeclat Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
